ArticleScientific reports2025

SLC35A2 is a novel prognostic biomarker and promotes cell proliferation and metastasis via Wnt/β-catenin/EMT signaling pathway in breast cancer.

Rushu Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.